Rezolute, Inc

275 Shoreline Dr Ste 500
Redwood City, CA 94065

Rezolute, Inc., based in Redwood City, California, is a biopharmaceutical company focused on developing innovative therapies for severe hypoglycemia associated with conditions such as tumor hyperinsulinism. The company has recently received Breakthrough Therapy Designation from the FDA for its lead product, Ersodetug, highlighting the urgent need for effective treatments in the oncology setting.

With a robust pipeline that includes programs targeting congenital and tumor hyperinsulinism, Rezolute is committed to advancing scientific research and improving patient outcomes. The company actively engages with investors and the medical community to foster collaboration and drive its mission forward.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.